ARVO: 2018
Show Description +
Pravin U. Dugel, MD, discusses the HAWK and HARRIER studies, particularly with regard to whether the disease activity assessment performed after the first Q12 interval can predict which patients can be extended to 12 weeks. He also explains why this is important from a clinical standpoint.
Posted: 5/01/2018
Pravin U. Dugel, MD, discusses the HAWK and HARRIER studies, particularly with regard to whether the disease activity assessment performed after the first Q12 interval can predict which patients can be extended to 12 weeks. He also explains why this is important from a clinical standpoint.
Posted: 5/01/2018
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2018.
Please log in to leave a comment.